Powered by BillionToOne's patent-pending molecular counting technology, UNITY is the only prenatal screen that tests cell-free fetal DNA for cystic fibrosis, spinal muscular atrophy (SMA) and sickle cell disease using just one tube of blood from the mother. https://unityscreen.com/

Read More —>

BillionToOne, inventors of the patent-pending molecular counter platform, today announced it has closed its highly oversubscribed Series A funding round of $15 million with select global investors.

Read More —>

Working the lab of Nobel laureate Andrew Fire, Sukrit Silas discovered how bacteria use CRISPR, which is part of their immune system, to learn to attack viruses that are made of the genetic material RNA. His company, BillionToOne, has raised $2.5 million and is developing diagnostics for beta thalassemia and Down syndrome.

Read More —>